Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin for Colorectal Adenoma Chemoprevention
NCT00002527Phase 3Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- May 1993
- Primary completion
- Mar 2003
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in colorectal cancer (CRC) comparing Aspirin with Placebo (2 arms). Primary endpoints: Reduction in size of tumors at 4 years, Reduction in number of tumors at 4 years and 1 more. Started May 1993; status: completed.
02
Drugs
aspirin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00002527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002527.